19.8 C
Los Angeles
Wednesday, November 27, 2024

Bayer shares soar 12% after key U.S. legal win against Roundup cancer claims

WorldBayer shares soar 12% after key U.S. legal win against Roundup cancer claims


CHICAGO, ILLINOIS – MAY 14: Roundup weed killing products are offered for sale at a home improvement store on May 14, 2019 in Chicago, Illinois. A jury yesterday ordered Monsanto, the maker of Roundup, to pay a California couple more than $2 billion in damages after finding that the weed killer had caused their cancer. This is the third jury to find Roundup had caused cancer since Bayer purchased Monsanto about a year ago. Bayer’s stock price has fallen more than 40 percent since the takeover. (Photo by Scott Olson/Getty Images)

Scott Olson | Getty Images News | Getty Images

Bayer shares jumped in morning trade as the German life sciences company said it scored a legal victory in its suit over claims that exposure to its popular Roundup weed killer led to cancer.

The stock was up 11.67% at 11:44 a.m. London time.

The company on Thursday announced that the 3rd U.S. Circuit Court of Appeals in Philadelphia found in its favor against plaintiff David Schaffner’s claim alleging that the Monsanto corporation — which Bayer acquired in 2018 — violated state law by failing to add a cancer warning to the Roundup label.

This breaking news story is being updated.



Source link

Check out our other content

Check out other tags:

Most Popular Articles